HYOGO COLLEGE OF MEDICINE

Patent Applications and Registrations

Patent applications and USPTO patent grants for HYOGO COLLEGE OF MEDICINE.The latest application filed is for "lipocalin-type prostaglandin d2 synthase production promoting agent".

Company Profile

13.18.24

HYOGO COLLEGE OF MEDICINE - Nishinomiya JP
HYOGO COLLEGE OF MEDICINE - Nishinomiya City, Hyogo JP
Hyogo College of Medicine - Hyogo JP
HYOGO COLLEGE OF MEDICINE - Nishinomiya-shi, Hyogo JP
HYOGO COLLEGE OF MEDICINE - Nishinomiya-shi JP
HYOGO COLLEGE OF MEDICINE; - Nishinomiya-shi JP
Hyogo College of Medicine - Hyogo-ken JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent Grant 11,389,486 - Yamahara , et al. July 19, 2	2022-07-19
Swallowing diagnosis apparatus and storage medium Grant 11,246,526 - Yoshioka , et al. February 15, 2	2022-02-15
Lipocalin-type Prostaglandin D2 Synthase Production Promoting Agent App 20200338135 - MATSUYAMA; Tomohiro ; et al.	2020-10-29
Anti-il-6 Receptor Antibody-containing Medicinal Composition For Preventing Post-surgical Adhesion App 20200299391 - FUJIMOTO; Jiro ; et al.	2020-09-24
Medicine For Treating Advanced Or Recurrent Cancer Patient Being Non-responsive Or Non-tolerant To Standard Chemotherapy And Inc App 20200268703 - KIKUCHI; Shojiro ; et al.	2020-08-27
Il-33 Antagonist-containing Therapeutic Agent For Endometriosis App 20200190182A1 -	2020-06-18
Novel Biomarkers For Cancer Immunotherapy App 20200024349 - Matsumoto; Seiji ; et al.	2020-01-23
Dysphagia test device, dysphagia test method, dysphagia treatment device, and stimulating current setting method Grant 10,518,087 - Oku , et al. Dec	2019-12-31
Method For Producing Amniotic Mesenchymal Stromal Cell Composition, Method For Cryopreserving The Same, And Therapeutic Agent App 20190343892 - YAMAHARA; Kenichi ; et al.	2019-11-14
Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent Grant 10,441,611 - Yamahara , et al. Oc	2019-10-15
Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent Grant 10398738 -	2019-09-03
Swallowing Diagnosis Apparatus And Storage Medium App 20190209073 - Yoshioka; Michifumi ; et al.	2019-07-11
Swallowing Training Apparatus App 20190125243 - Oku; Yoshitaka ; et al.	2019-05-02
Dysphagia Test Device, Dysphagia Test Method, Dysphagia Treatment Device, And Stimulating Current Setting Method App 20180117317 - Oku; Yoshitaka ; et al.	2018-05-03
Atopic dermatitis model animal and use thereof Grant 9,949,465 - Yamanishi , et al. April 24, 2	2018-04-24
Therapeutic Agent For Cancer Which Comprises Combination Of Il-18 And Molecule-targeting Antibody App 20170224791 - OKAMURA; Haruki ; et al.	2017-08-10
Swallowing estimation device, information terminal device, and storage medium Grant 9,649,062 - Oku , et al. May 16, 2	2017-05-16
Swallowing assist device Grant 9,440,075 - Oku September 13, 2	2016-09-13
Method For Producing Amniotic Mesenchymal Stromal Cell Composition, Method For Cryopreserving The Same, And Therapeutic Agent App 20160228474 - YAMAHARA; Kenichi ; et al.	2016-08-11
Swallowing Estimation Device, Information Terminal Device, And Storage Medium App 20160143575 - OKU; Yoshitaka ; et al.	2016-05-26
Atopic Dermatitis Model Animal And Use Thereof App 20160057978 - YAMANISHI; Kiyofumi ; et al.	2016-03-03
Benzimidazole derivative and use thereof Grant 9,212,169 - Tsujikawa , et al. December 15, 2	2015-12-15
Swallowing Assist Device App 20150165201 - OKU; Yoshitaka	2015-06-18
Blood Marker For Renal Cancer App 20150044691 - Matsuo; Eiichi ; et al.	2015-02-12
Novel Benzimidazole Derivative And Use Thereof App 20150011600 - Tsujikawa; Kazutake ; et al.	2015-01-08
Blood Marker For Renal Cancer App 20130171660 - Matsuo; Eiichi ; et al.	2013-07-04
Compositions, methods and animal models for screening therapeutics for TH2-type disease Grant 8,440,412 - Nakanishi , et al. May 14, 2	2013-05-14
Composition For Inducing Th2 Cell, Therapeutic Composition For Th2-type Disease, And Use Of Same App 20110252487 - Nakanishi; Kenji ; et al.	2011-10-13
V.gamma.9V.delta.2 T cell proliferation agent, method for producing activated V.gamma.9V.delta.2 T cells, and uses thereof Grant 7,749,760 - Okamura , et al. July 6, 2	2010-07-06
Method For Preventing Or Treating Cisplatin-induced Nephrotoxicity App 20100035853 - UEDA; Haruyasu ; et al.	2010-02-11
Vgamma9Vdelta2 T cell proliferation agent, method for producing activated Vgamma9Vdelta2 T cells, and uses thereof App 20100009447 - Okamura; Haruki ; et al.	2010-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.